AI Decision Infrastructure
#1 in Top 100 AI Companies Clutch, 2025
from biomarker intelligence and cohort analysis to drug asset valuation and licensing strategy
OmicsLayer™
Convert existing biomarker data Into revenue capacity
- Reuse biomarker workflows, analysis outputs, evidence templates, and provenance.
- Connect multi-omics, clinical, assay, cohort, and metadata sources into one governed intelligence layer.
- Answer sponsor feasibility and cohort questions faster.
- Prepare pharma-facing evidence packages without rebuilding everything manually each time.
AssetLens™
Model the cost-to-value path of your drug asset.
- For biotech CEOs, BD teams, CFOs, pharma scouting, investors.
- Commercial report covering revenue forecast, clinical landscape, licensing benchmarks, development costs, and NPV scenarios.
- Outcome: clearer asset value, stronger licensing strategy, better fundraising and portfolio decisions.
Trusted by Life science innovators worldwide
Proven Client Implementations
Proven Client Implementations
Trusted by Industry Leaders:
Blackthorn AI is a life science AI product company building decision intelligence platforms for biotech, pharma, and clinical data teams.
Explore our products0+
AI systems delivered
0+
Peer-reviewed publication
0+
PhD-Level Experts
0+
Years of full-cycle development experience
Blackthorn AI’s team combines deep technical expertise with a thorough understanding of industry challenges, offering bespoke AI solutions that empower businesses to innovate and excel in a competitive market.
Delve into our latest research and publications demonstrating our commitment to AI and software development excellence
All Publications
HbA1c and leukocyte mtDNA levels as major factors associated with post-COVID-19 syndrome in type 2 diabetes patients
Ensembling machine learning models to boost molecular affinity prediction
Filling the Gap in LogP and pKa Evaluation for Saturated Fluorine-Containing Derivatives With Machine Learning
Enhancing Solar Energy Production Forecasting Using Advanced Machine Learning and Deep Learning Techniques: A Comprehensive Study on the Impact of Meteorological Data
#1 in Top 100 AI Companies Clutch, 2024
Straight to Business?
Blackthorn AI empowers organisations to solve complex, cross-industry challenges with intelligent, scalable solutions
Book a MeetingHow can AI accelerate drug discovery for biotech startups?
+AI can reduce early-stage drug discovery costs by up to 80% through predictive modeling, automated screening, and molecular simulation. At Blackthorn.ai, we develop custom AI pipelines that analyze complex biological data, identify promising compounds, and shorten the R&D cycle from years to months – helping biotech startups reach proof-of-concept faster and attract investor confidence.
How do you ensure data security and regulatory compliance?
+Data protection in biotech is non-negotiable. We follow industry-grade standards like ISO 27001, HIPAA, and GDPR, implementing encrypted pipelines, controlled access layers, and secure on-premise or hybrid deployments. This ensures that sensitive genomic, clinical, and research data remains fully protected throughout development.
Can AI help us manage and analyze multi-omics data?
+Absolutely. We build AI-powered multi-omics platforms that unify genomics, proteomics, and metabolomics datasets into one scalable environment. Our tools automate preprocessing, quality control, and cross-omics correlation – allowing scientists to focus on discovery instead of data wrangling.
We’re a small biotech startup – is AI development realistic for us?
+Yes – and it’s often the smartest move you can make early on. We offer a 90-Day AI Discovery Sprint, where we build your first MVP (AI model or platform prototype) fast and cost-efficiently. This approach helps startups demonstrate technical feasibility to investors and gain early market traction without committing to a full-scale development yet.
How do you measure success in biotech AI projects?
+We define clear KPIs from day one: prediction precision, experiment optimization rate, cost reduction, and time-to-result. Each milestone is benchmarked to measurable ROI, ensuring transparency and progress tracking throughout the project.